Amir Hefni, PhD MBA.

CEO at Resolution Therapeutics

Speaker

Amir is the CEO of Resolution Therapeutics. Prior to joining Resolution, he was the Global Head of Cell and Gene Therapy at Novartis where he was responsible for the company’s global product development, manufacturing, supply chain and commercialisation of innovative cell therapies. Previously, he was a Global Asset Lead in Oncology at Ipsen and was Executive Director US Oncology at Bristol-Myers Squibb. Amir holds a BSc and PhD in Pharmacology from King’s College London and an MBA from Warwick Business School.